Aurora Cannabis Inc. (ACB) |
| 3.67 0.2 (5.76%) 05-28 16:00 |
| Open: | 3.45 |
| High: | 3.7 |
| Low: | 3.41 |
| Volume: | 720,623 |
| Market Cap: | 208(M) |
| PE Ratio: | -3.4 |
| Exchange: | NASDAQ Global Select |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.13 |
| Resistance 1: | 3.79 |
| Pivot price: | 3.42 |
| Support 1: | 3.23 |
| Support 2: | 2.69 |
| 52w High: | 6.665 |
| 52w Low: | 3.07 |
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| EPS | -1.090 |
| Book Value | 6.900 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.273 |
| Profit Margin (%) | -22.51 |
| Operating Margin (%) | 2.32 |
| Return on Assets (ttm) | -4.4 |
| Return on Equity (ttm) | -15.5 |
Thu, 28 May 2026
Aurora Cannabis (NASDAQ: ACB) schedules Q4 and FY 2026 call - Stock Titan
Thu, 28 May 2026
Aurora Cannabis bosses to field investor questions on June 11 results call - Stock Titan
Thu, 21 May 2026
Aurora Cannabis (ACB) plans Aug. 7, 2026 virtual annual meeting - Stock Titan
Thu, 14 May 2026
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science - PR Newswire
Wed, 15 Apr 2026
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets - PR Newswire
Tue, 03 Mar 2026
Canaccord Initiates Aurora Cannabis Inc. (ACB) With C$10 Price Target - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |